Home
>
National Drug Code (NDC)
>
Afinitor
Afinitor - 0078-0620-51 - (everolimus)
Drug Information of Afinitor
| Product NDC: | 0078-0620 |
| Proprietary Name: | Afinitor |
| Non Proprietary Name: | everolimus |
| Active Ingredient(s): | 7.5 mg/1 & nbsp; everolimus |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Afinitor
| Product NDC: | 0078-0620 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022334 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110729 |
Package Information of Afinitor
| Package NDC: | 0078-0620-51 |
| Package Description: | 28 BLISTER PACK in 1 CARTON (0078-0620-51) > 1 TABLET in 1 BLISTER PACK (0078-0620-61) |
NDC Information of Afinitor
| NDC Code | 0078-0620-51 |
| Proprietary Name | Afinitor |
| Package Description | 28 BLISTER PACK in 1 CARTON (0078-0620-51) > 1 TABLET in 1 BLISTER PACK (0078-0620-61) |
| Product NDC | 0078-0620 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | everolimus |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110729 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | EVEROLIMUS |
| Strength Number | 7.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
